Reply SIR-We write in response to the comments of Das and colleagues on our recent review of blood pressure in acute stroke [1] , and in particular their concerns in respect of the reduction of blood pressure following acute stroke in patients with severe (>70%) carotid artery disease. The design of our trials, Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS) (www.le.ac.uk/ CHHIPS/HomePage.html) and Continue Or Stop postStroke Antihypertensives Collaborative Study (COSSACS) (www.le.ac.uk/COSSACS/COSSACShome.html), specifically excludes patients with known carotid artery stenosis (>70%). Furthermore, lisinopril is being used as one of the depressor therapies in the CHHIPS trial. Agents acting on the renin-angiotensin system have been shown to reduce systemic blood pressure without detrimental effects on cerebral blood flow in acute stroke patients with [2] and without [3] significant carotid disease. Also, there is preliminary evidence that such agents reduce the secondary outcome of cardiovascular morbidity and mortality at 1 year, albeit in a small study of patients with severe hypertension where those with known carotid artery stenosis of >70% were excluded [4] . However, a sub-study of the CHHIPS trial will assess the effects of acute blood pressure manipulation on neurological outcome and relate this to the degree of atheromatous disease of the distal internal carotid and proximal middle cerebral arteries as determined by CT or MR angiography studies. Nonetheless, hypertension remains a common problem in the everyday clinical management of acute stroke patients, and is associated with an increased risk of death and dependency for both ischaemic and haemorrhagic stroke patients [5] . This important issue is the subject of ongoing multi-centre UK trials (CHHIPS, COSSACS), which will also provide data on the relevance of concomitant carotid and middle cerebral artery disease, as well as stroke severity, stroke subtype, age, degree of blood pressure reduction, and class, dose and route of antihypertensive therapy.
